The present invention relates to a compound represented as formula (I): ##STR1##

wherein

    • A is R2-N(R3R4), ##STR2##

      wherein Ar is a substituted or unsubstituted phenyl group, m is an integer between 0 to 4, Het is a substituted or unsubstituted 4 to 8 member heterocyclic group, n is an integer between 0 to 4; R3 and R4 are independently H, ##STR3##

      or ##STR4##

      R2 is ##STR5## ##STR6## ##STR7## ##STR8##

      or ##STR9##

      wherein X is (CH2)y—Ar, R6, or (CH2)z-Het, wherein Ar is a substituted or unsubstituted phenyl group, y is an integer between 0 to 2, R6 is a substituted or unsubstituted linear or a branched C1-10 alkyl group, z is an integer between 0 to 2, and Het is a 6 to 12 member heterocyclic group;

    • B is OR1 or ##STR10##

      wherein R1 is H or C2-5 alkyl group.

  •  
    Web www.patentalert.com

    < Compounds with high monoamine transporter affinity

    < Neurocognitive function EEG measurement method and system

    > Compounds useful for the treatment of cancer, compositions thereof and methods therewith

    > Inhibitors of glycogen synthase kinase 3

    ~ 00258